Results 31 to 40 of about 39,920 (269)

Câncer de Mama

open access: yesRevista Brasileira de Cancerologia, 2001
Conduta diagnóstico-terapêutica do INCA para Câncer de Mama.
Instituto Nacional de Câncer
doaj   +1 more source

Consenso mexicano de cáncer mamario. Cuidados multidisciplinarios en cáncer de mama

open access: yesGaceta Mexicana de Oncolog�a
El cáncer mamario impacta en diversas esferas de la vida del paciente y su entorno familiar y social. Se trata de una enfermedad compleja que requiere un abordaje multidisciplinario tanto para el diagnóstico como para el tratamiento, así como en lo relativo al manejo de la toxicidad mediata y tardía del tratamiento sistémico y la radioterapia y también
Enrique Soto-Pérez-de-Celis   +31 more
openaire   +2 more sources

Recommended age groups and frequency of mammography screening : a systematic review [PDF]

open access: yes, 2014
Esta revisão teve por objetivo avaliar a força de evidência do atual indicador de desempenho português relativo ao rastreio do Câncer da Mama através da mamografia, de modo a determinar o grupo etário e a periodicidade recomendadas.
Alves Pereira C   +14 more
core   +2 more sources

Consenso mexicano de cáncer mamario. Manejo del cáncer de mama en poblaciones especiales

open access: yesGaceta Mexicana de Oncolog�a
El cáncer mamario en poblaciones especiales (mujeres jóvenes, de edad avanzada, en embarazo o lactancia, hombres) requiere de consideraciones especiales de manejo sistémico, quirúrgico y radioterapia. La décima actualización del Consenso Mexicano Sobre Diagnóstico y Tratamiento del Cáncer Mamario (Colima, enero de 2023) es publicada por sus autores en ...
Laura Torrecillas-Torres   +16 more
openaire   +2 more sources

Cancer Health Disparities Among Patients With Early-Stage Estrogen Receptor–Positive Breast Cancer: Impact of Public Versus Private Health Care on Diagnosis-to-Treatment Interval in Brazil

open access: yesJCO Global Oncology
PURPOSEIn 2013, Brazil implemented a federal law (Law 12.732/2012) mandating cancer treatment to begin within 60 days of diagnosis. Among women with newly diagnosed estrogen receptor–positive (ER+) nonmetastatic breast cancer, we describe the diagnosis ...
Romualdo Barroso-Sousa   +20 more
doaj   +1 more source

Costs of mammogram campaigns in the Regional Health Division of Marília, São Paulo State, Brazil, 2005-2006 [PDF]

open access: yes, 2011
The aim of this study was to measure the direct costs of mammogram campaigns conducted by the Regional Health Division of Marília, São Paulo State, Brazil, in 2005 and 2006. A total of 11,952 mammograms were performed.
Ciconelli, Rozana Mesquita   +2 more
core   +3 more sources

Dose dense versus 3 weekly AC during neoadjuvant chemoimmunotherapy for triple negative breast cancer

open access: yesnpj Breast Cancer
Neoadjuvant pembrolizumab plus chemotherapy (P + CT) has emerged as a standard of care for stage II-III triple-negative breast cancer (TNBC). However, the best anthracycline-cyclophosphamide (AC) schedule remains to be determined.
Renata Colombo Bonadio   +22 more
doaj   +1 more source

Self-care and breast cancer prevention: perceptions of women with motor disabilities / Autocuidado e prevenção de câncer de mama: percepções de mulheres com deficiência motora

open access: yesRevista de Pesquisa Cuidado é Fundamental Online, 2023
Objetivo: conhecer a percepção das mulheres com deficiência quanto ao autocuidado e prevenção do câncer de mama. Método: estudo transversal, descritivo e qualitativo no qual participaram 11 mulheres com deficiência.
Diego Augusto Lopes Oliveira   +5 more
doaj   +1 more source

Dieta e câncer no Nordeste do Brasil: avaliação da relação entre alimentação e consumo de grupos de alimentos e câncer de mama [PDF]

open access: yes, 2008
Realizou-se um estudo do tipo caso-controle de base hospitalar no Município de João Pessoa, Paraíba, Brasil. Participaram 183 indivíduos (89 casos e 94 controles) na faixa etária entre 30 e 80 anos, com pareamento por idade.
COSTA, Maria José de Carvalho   +3 more
core   +2 more sources

TRAIL‐PEG‐Apt‐PLGA nanosystem as an aptamer‐targeted drug delivery system potential for triple‐negative breast cancer therapy using in vivo mouse model

open access: yesMolecular Oncology, EarlyView.
Aptamers are used both therapeutically and as targeting agents in cancer treatment. We developed an aptamer‐targeted PLGA–TRAIL nanosystem that exhibited superior therapeutic efficacy in NOD/SCID breast cancer models. This nanosystem represents a novel biotechnological drug candidate for suppressing resistance development in breast cancer.
Gulen Melike Demirbolat   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy